DR Horton Inc (DHI)
Official siteCONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE
Market Cap: $39.51B
Last updated: Nov 17, 2026 at 4:38 PM ET
DR Horton Inc (DHI) Statistics
DR Horton (DHI) has a market cap of $39.51B and an enterprise value of $44.54B. Its share count is down 7.20% from a year earlier. Its trailing P/E of 14.2x is above its 10-year median of 11.0x.
Total Valuation
Enterprise value is 12.74% above the market cap, as debt exceeds cash.
| Market Cap | $39.51B |
|---|---|
| Enterprise Value | $44.54B |
| Latest price (Nov 17, 2026) | $143.54 |
Key Dates
The next earnings report is expected on Jan 18, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 12, 2026.
| Next Earnings Date | Jan 18, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Last Ex-Dividend Date | Nov 12, 2026 |
| Next Payment Date | Nov 19, 2026 |
| Fiscal Year End | September |
Valuation Ratios
Sales and book value multiples are 1.2x and 1.7x. Its year-end P/E ranged from 5.5x to 19.1x from 2016 to 2025.
| P/E Ratio | 14.2x |
|---|---|
| Forward P/E | 15.3x |
| P/S Ratio | 1.2x |
| Forward P/S | 1.3x |
| P/B Ratio | 1.7x |
| P/TBV Ratio | 1.7x |
| P/FCF Ratio | 12.6x |
| P/OCF Ratio | 11.8x |
| PEG Ratio | 0.7 |
Enterprise Valuation
Counting debt and cash, the company is valued at 10.8x EBITDA and 14.2x free cash flow.
| EV / Earnings | 14.4x |
|---|---|
| EV / Sales | 1.3x |
| EV / EBITDA | 10.8x |
| EV / EBIT | 10.9x |
| EV / FCF | 14.2x |
Price Statistics
The stock is up 1.07% over 52 weeks and trades 1.51% above its 50-day average.
| Beta (1Y) | 0.79 |
|---|---|
| 52-Week Change | +1.07% |
| 1-Month Change | +6.45% |
| 3-Month Change | -5.15% |
| 6-Month Change | +6.88% |
| 5-Year Change | +63.55% |
| 10-Year Change | +406.42% |
| Total Return (1Y) | +2.37% |
| Total Return (3Y CAGR) | +4.55% |
| Total Return (5Y CAGR) | +7.98% |
| Return vs SPY (1Y) | -7.59% |
| Max Drawdown (1Y) | -21.25% |
| Max Drawdown (3Y) | -41.27% |
| Sharpe Ratio (1Y) | 0.11 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $141.41 |
| 200-Day Average | $146.78 |
| 52-Week Range | $129.96 to $169.71 |
| RSI (14 Days) | 47.6 |
| Average Volume (20 Days) | 3.37M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.82x current liabilities, and total debt is 0.30x shareholder equity.
| Current Ratio | 5.82x |
|---|---|
| Quick Ratio | 0.43x |
| Debt / Equity | 0.30x |
| Debt / EBITDA | 1.69x |
| Debt / FCF | 2.22x |
Returns and Efficiency
Return on invested capital is 10.01% over the last 12 months, against a 5-year average of 12.01%.
| Return on Equity (ROE) | 12.99% |
|---|---|
| Return on Assets (ROA) | 8.48% |
| Return on Invested Capital (ROIC) | 10.01% |
| Return on Capital Employed (ROCE) | 12.98% |
| ROE (5Y Average) | 22.73% |
| ROA (5Y Average) | 15.02% |
| ROIC (5Y Average) | 12.01% |
| Asset Turnover | 0.91x |
| Inventory Turnover | 0.97x |
Taxes
Income tax took 24.45% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.00B |
|---|---|
| Effective Tax Rate | 24.45% |
Scores
DHI has an Altman Z-Score of 5.33, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.33 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $33.35B over the last 12 months is down 3.54% from the 12 months before.
| Revenue | $33.35B |
|---|---|
| Revenue Growth (YoY) | -3.54% |
| Gross Profit | $7.54B |
| Operating Income | $3.81B |
| Pretax Income | $4.10B |
| Net Income | $3.09B |
| EBITDA | $4.21B |
| EBIT | $4.10B |
| Reported EPS (TTM) | $10.14 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 65.24% of the $36.51B in total assets.
| Cash and Equivalents | $2.08B |
|---|---|
| Total Debt | $7.11B |
| Net Debt | $5.03B |
| Net Debt Per Share | $17.84 |
| Working Capital | $23.87B |
| Shareholder Equity | $23.82B |
| Book Value Per Share | $84.41 |
| Tangible Book Value | $23.66B |
| Tangible Book Per Share | $83.83 |
| Total Assets | $36.51B |
| Total Liabilities | $12.10B |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $150.40M of capital spending, operating cash flow left $3.20B of free cash flow.
| Operating Cash Flow | $3.35B |
|---|---|
| Capital Expenditures | $150.40M |
| Free Cash Flow | $3.20B |
| FCF Per Share | $11.45 |
| Depreciation and Amortization | $112.20M |
| Dividends Paid | $506.70M |
| Share Repurchases | $2.91B |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is 11.43%, against a 5-year average of 17.61%.
| Gross Margin | 22.61% |
|---|---|
| Operating Margin | 11.43% |
| Pretax Margin | 12.28% |
| Net Margin | 9.28% |
| EBITDA Margin | 12.62% |
| EBIT Margin | 12.28% |
| FCF Margin | 9.60% |
| Gross Margin (5Y Average) | 27.14% |
| Operating Margin (5Y Average) | 17.61% |
| Net Margin (5Y Average) | 13.97% |
Growth
Revenue grew 0.76% a year over 3 years, and EPS fell 9.85% a year.
| Revenue Growth (3Y CAGR) | +0.76% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.02% |
| EPS Growth (3Y CAGR) | -9.85% |
| EPS Growth (5Y CAGR) | -2.50% |
| FCF Growth (3Y CAGR) | +99.49% |
| FCF Growth (5Y CAGR) | +23.68% |
| Operating Income Growth (3Y CAGR) | -16.39% |
| Book Value Per Share Growth (2Y CAGR) | +10.27% |
| Tangible Book Per Share Growth (2Y CAGR) | +10.30% |
Dividends and Yields
DHI pays out 16.87% of earnings as dividends.
| Dividend Per Share (Annual) | $2.00 |
|---|---|
| Dividend Yield | 1.39% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +21.28% |
| Dividend Growth (5Y CAGR) | +17.88% |
| Payout Ratio | 16.87% |
| FCF Payout Ratio | 15.82% |
| Earnings Yield | 7.04% |
| FCF Yield | 7.91% |
| Buyback Yield | 7.17% |
| Shareholder Yield | 8.42% |
Stock Splits
The last split was a 3-for-2 forward split on Jan 13, 2004.
| Last Split Date | Jan 13, 2004 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 10 similar companies, DHI has the 3rd highest P/E and the 6th highest P/S.
P/E RatioPeer median 12.3x
P/S RatioPeer median 0.9x
ROICPeer median 7.61%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -8.99%
Dividend YieldPeer median 0.00%
| P/E Ratio | 14.2x vs 12.3x median |
|---|---|
| P/S Ratio | 1.2x vs 0.9x median |
| ROIC | 10.01% vs 7.61% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -3.54% vs -8.99% median |
| Dividend Yield | 1.39% vs 0.00% median |
Analyst Forecast
Consensus estimates put EPS growth at 4.18% a year over the next 2 fiscal years.
| EPS Growth Forecast (2Y CAGR) | +4.18% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DHI
What is DHI's market cap?
DR Horton has a market cap of $39.51B. Its enterprise value, which adds debt and subtracts cash, is $44.54B.
What is DHI's P/E ratio?
DR Horton has a trailing P/E ratio of 14.2x and a forward P/E of 15.3x.
How many shares of DHI are outstanding?
DR Horton has 282.20M shares outstanding. The count is down 7.20% from a year earlier.
Does DHI pay a dividend?
Yes. DR Horton pays $2.00 a share a year, a dividend yield of 1.39%.
How much debt does DHI have?
DR Horton has $7.11B of total debt and $2.08B of cash and equivalents, a net debt position of $5.03B.
DHI pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors